10Y UST4.88%+0.41%30Y MTG7.11%-0.97%SOFR3.89%+0.26%VNQ$96.44-0.60%XLRE$44.37-0.50%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire

Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020

Via PR Newswire · November 12, 2026
Compiled by Real Estate Trail Editorial · November 12, 2026

Why this matters

Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.

Editorial analysis · Real Estate Trail Editorial

Excerpt from PR Newswire:
Facility will manufacture injectable medicines, including retatrutide Site will create 850 high-wage jobs and 2,000 construction jobs INDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

More from the wire